Source: International Congress 2019 – Imaging in respiratory disease: novel technologies in 2019
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Eaden (Sheffield, United Kingdom), H. Chan (Sheffield, United Kingdom), P. Hughes (Sheffield, United Kingdom), N. Weatherly (Sheffield, United Kingdom), M. Austin (Sheffield, United Kingdom), L. Smith (Sheffield, United Kingdom), J. Lithgow (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), S. Renshaw (Sheffield, United Kingdom), M. Buch (Leeds, United Kingdom), C. Leonard (Manchester, United Kingdom), S. Skeoch (Manchester, United Kingdom), N. Chaudhuri (Manchester, United Kingdom), G. Parker (Manchester, United Kingdom), S. Bianchi (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom). Hyperpolarised 129-xenon diffusion-weighted MRI in interstitial lung disease. 3157

Member's Comments

No comment yet.

Related content which might interest you: Regional hyperpolarised 129-xenon diffusion-weighted MRI in patients with IPF Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease Year: 2020 Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial Source: Eur Respir J 2009; 34: 1311-1321 Year: 2009 Detection and monitoring of lung inflammation in cystic fibrosis during respiratory tract exacerbation using diffusion-weighted magnetic resonance imaging Source: Eur Respir J, 50 (1) 1601437; 10.1183/13993003.01437-2016 Year: 2017 Hyperpolarised 129Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis Source: Eur Respir J, 53 (5) 1802188; 10.1183/13993003.02188-2018 Year: 2019 MRI and CT imaging of in vivo models of drug-induced interstitial lung diseases. Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease Year: 2018 MDCT and MRI DWI early signs of COPD Source: Annual Congress 2012 - Standard of care, incidential findings, image acquisition Year: 2012 Gadofosveset-enhanced lung magnetic resonance imaging to detect ongoing vascular leak in pulmonary fibrosis Source: Eur Respir J, 51 (5) 1800171; 10.1183/13993003.00171-2018 Year: 2018 Comparison of 1H MRI and 3He MRI ventilation images in patients with cystic fibrosis and patients with lung cancer Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities Year: 2018 Magnetic resonance imaging (MRI) as a non-invasive, radiation-free imaging modality to study the onset and progression of lung disease in infants and young children with cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: detection and monitoring of early lung disease Year: 2011 Novel magnetic resonance technique for functional imaging of cystic fibrosis lung disease Source: Eur Respir J, 50 (6) 1701464; 10.1183/13993003.01464-2017 Year: 2017 Imaging of cystic fibrosis: functional MRI versus conventional CT Source: Annual Congress 2007 - Imaging of inflammatory airway diseases Year: 2007 Magnetic resonance imaging (MRI) of the lung as a tool for the non-invasive evaluation of drugs in rat models of airways diseases Source: Annual Congress 2005 - New modalities and application in lung and airway imaging Year: 2005 Computed tomography and magnetic resonance imaging: past, present and future Source: Eur Respir J 2002; 19: 3S-12S Year: 2002 Quantitative multivolume proton-magnetic resonance imaging in patients with cystic fibrosis lung disease: comparison with clinical indicators Source: Eur Respir J, 53 (5) 1702020; 10.1183/13993003.02020-2017 Year: 2019 Assessment with STIR MR imaging and PET-CT for malignant or benign lesion in the mediastinal and hilar lymph nodes Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques Year: 2007 The value of magnetic resonance imaging (MRI) with gadolinium as a noninvasive diagnostic method in cardiac sarcoidosis Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008 Whole-body magnetic resonance imaging in extrathoracic sarcoidosis Source: Eur Respir J 2014; 43: 1812-1815 Year: 2014 Fourier-decomposition of free-breathing pulmonary proton MRI in asthma Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Comparison of in-vivo lung morphometry models from multiple b-value diffusion-weighted MRI in healthy controls, IPF and COPD patients Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses Year: 2017